Literature DB >> 23921123

Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.

Maria E Figueroa1, Shann-Ching Chen, Anna K Andersson, Letha A Phillips, Yushan Li, Jason Sotzen, Mondira Kundu, James R Downing, Ari Melnick, Charles G Mullighan.   

Abstract

Acute lymphoblastic leukemia (ALL) is the commonest childhood malignancy and is characterized by recurring structural genetic alterations. Previous studies of DNA methylation suggest epigenetic alterations may also be important, but an integrated genome-wide analysis of genetic and epigenetic alterations in ALL has not been performed. We analyzed 137 B-lineage and 30 T-lineage childhood ALL cases using microarray analysis of DNA copy number alterations and gene expression, and genome-wide cytosine methylation profiling using the HpaII tiny fragment enrichment by ligation-mediated PCR (HELP) assay. We found that the different genetic subtypes of ALL are characterized by distinct DNA methylation signatures that exhibit significant correlation with gene expression profiles. We also identified an epigenetic signature common to all cases, with correlation to gene expression in 65% of these genes, suggesting that a core set of epigenetically deregulated genes is central to the initiation or maintenance of lymphoid transformation. Finally, we identified aberrant methylation in multiple genes also targeted by recurring DNA copy number alterations in ALL, suggesting that these genes are inactivated far more frequently than suggested by structural genomic analyses alone. Together, these results demonstrate subtype- and disease-specific alterations in cytosine methylation in ALL that influence transcriptional activity, and are likely to exert a key role in leukemogenesis.

Entities:  

Mesh:

Year:  2013        PMID: 23921123      PMCID: PMC3696550          DOI: 10.1172/JCI66203

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  70 in total

1.  Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.

Authors:  Eric Schafer; Rafael Irizarry; Sandeep Negi; Emily McIntyre; Donald Small; Maria E Figueroa; Ari Melnick; Patrick Brown
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

2.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.

Authors:  Rebecca R Selzer; Todd A Richmond; Nathan J Pofahl; Roland D Green; Peggy S Eis; Prakash Nair; Arthur R Brothman; Raymond L Stallings
Journal:  Genes Chromosomes Cancer       Date:  2005-11       Impact factor: 5.006

4.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

5.  Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; J Racquel Collins-Underwood; Letha A A Phillips; Michael G Loudin; Wei Liu; Jinghui Zhang; Jing Ma; Elaine Coustan-Smith; Richard C Harvey; Cheryl L Willman; Fady M Mikhail; Julia Meyer; Andrew J Carroll; Richard T Williams; Jinjun Cheng; Nyla A Heerema; Giuseppe Basso; Andrea Pession; Ching-Hon Pui; Susana C Raimondi; Stephen P Hunger; James R Downing; William L Carroll; Karen R Rabin
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

6.  Comprehensive methylome map of lineage commitment from haematopoietic progenitors.

Authors:  Hong Ji; Lauren I R Ehrlich; Jun Seita; Peter Murakami; Akiko Doi; Paul Lindau; Hwajin Lee; Martin J Aryee; Rafael A Irizarry; Kitai Kim; Derrick J Rossi; Matthew A Inlay; Thomas Serwold; Holger Karsunky; Lena Ho; George Q Daley; Irving L Weissman; Andrew P Feinberg
Journal:  Nature       Date:  2010-08-15       Impact factor: 49.962

Review 7.  Global genomic characterization of acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; James R Downing
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

8.  Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.

Authors:  Hui Yang; Tapan Kadia; Lianchun Xiao; Carlos E Bueso-Ramos; Koyu Hoshino; Deborah Ann Thomas; Susan O'Brien; Elias Jabbour; Sherry Pierce; Gary L Rosner; Hagop M Kantarjian; Guillermo Garcia-Manero
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

9.  Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.

Authors:  Shinobu Tsuzuki; Masao Seto; Mel Greaves; Tariq Enver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

10.  Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Authors:  C H Pui; D Pei; J T Sandlund; R C Ribeiro; J E Rubnitz; S C Raimondi; M Onciu; D Campana; L E Kun; S Jeha; C Cheng; S C Howard; M L Metzger; D Bhojwani; J R Downing; W E Evans; M V Relling
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

View more
  60 in total

Review 1.  Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui
Journal:  Front Med       Date:  2014-12-15       Impact factor: 4.592

Review 2.  Biology of childhood acute lymphoblastic leukemia.

Authors:  Deepa Bhojwani; Jun J Yang; Ching-Hon Pui
Journal:  Pediatr Clin North Am       Date:  2015-02       Impact factor: 3.278

Review 3.  The roles of AXIN2 in tumorigenesis and epigenetic regulation.

Authors:  Shuang Li; Chunpeng Wang; Xiaodong Liu; Shucheng Hua; Xin Liu
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

4.  Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.

Authors:  Kristen Meldi; Tingting Qin; Francesca Buchi; Nathalie Droin; Jason Sotzen; Jean-Baptiste Micol; Dorothée Selimoglu-Buet; Erico Masala; Bernardino Allione; Daniela Gioia; Antonella Poloni; Monia Lunghi; Eric Solary; Omar Abdel-Wahab; Valeria Santini; Maria E Figueroa
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

5.  Hypermethylation of antisense long noncoding RNAs in acute lymphoblastic leukemia.

Authors:  Gerald Arthur; Md Almamun; Kristen Taylor
Journal:  Epigenomics       Date:  2017-01-17       Impact factor: 4.778

Review 6.  Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine.

Authors:  Stephen P Hunger; Charles G Mullighan
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

Review 7.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

8.  Inferring a role for methylation of intergenic DNA in the regulation of genes aberrantly expressed in precursor B-cell acute lymphoblastic leukemia.

Authors:  Md Almamun; Olha Kholod; Alexei J Stuckel; Benjamin T Levinson; Nathan T Johnson; Gerald L Arthur; J Wade Davis; Kristen H Taylor
Journal:  Leuk Lymphoma       Date:  2017-01-17

Review 9.  Chromatin modifiers and the promise of epigenetic therapy in acute leukemia.

Authors:  S M Greenblatt; S D Nimer
Journal:  Leukemia       Date:  2014-03-10       Impact factor: 11.528

10.  Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.

Authors:  Sheryl M Gough; Liat Goldberg; Marbin Pineda; Robert L Walker; Yuelin J Zhu; Sven Bilke; Yang Jo Chung; Joseph Dufraine; Subhadip Kundu; Elad Jacoby; Terry J Fry; Susanna Fischer; Renate Panzer-Grümayer; Paul S Meltzer; Peter D Aplan
Journal:  Blood Adv       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.